2026-01-22 - Analysis Report
**Company Overview**
Intuitive Surgical is a medical device company that designs, manufactures, and markets robotic-assisted surgery systems.

**Return Rate Comparison**

| Ticker | Cumulative Return (Last Day) |
| --- | --- |
| ISRG (Intuitive Surgical) | 66.40% |
| VOO (S&P 500) | 91.55% |

Divergence: -25.15% (cumulative return difference)
Relative Divergence: 28.10% (located at the top 28.1% percentile of past data)

**Alpha, Beta Analysis**

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 49.0% | 29.0% | 44.0% | 1.2 | 57.2B |
| 2017-2019 | 40.0% | 29.0% | 23.0% | 1.4 | 70.6B |
| 2018-2020 | -8.0% | 29.0% | -29.0% | 1.2 | 97.8B |
| 2019-2021 | 26.0% | 21.1% | -18.0% | 1.2 | 128.8B |
| 2020-2022 | -18.0% | 48.9% | -16.0% | 1.2 | 95.1B |
| 2021-2023 | -12.0% | 48.9% | -13.0% | 1.4 | 120.9B |
| 2022-2024 | 35.0% | 38.0% | 16.0% | 1.3 | 187.1B |
| 2023-2025 | 60.0% | 28.0% | -2.0% | 1.2 | 203.0B |

**Recent Stock Price Fluctuations**

|  | Value |
| --- | --- |
| Close | $523.69 |
| Last-market | {'price': 523.69, 'previousClose': 527.44, 'change': -3.75} |
| 5-day SMA | $534.85 |
| 20-day SMA | $566.01 |
| 60-day SMA | $560.53 |

**RSI, PPO Index Indicators, Delta_Previous_Relative_Divergence, and Expected_Return**

| Indicator | Value |
| --- | --- |
| RSI | 28.35 |
| PPO | -1.24 |
| Hybrid Signal: Buy (Cash 0%): Risk Level: Medium (MRI 0.80) |
| Recent (20 days) relative divergence change | -12.90 (-) |
| 7-day Rank change | 30 (+) |
| 7-day Dynamic Expected Return change | 1.10 (+) |
| Expected Return (%) | 8.30% |

The recent price fluctuation shows a sharp decline. If the price is large, reflect the fluctuation issue in the analysis.

**Recent News & Significant Events**

[List of news articles provided]

It appears that Intuitive Surgical has been experiencing a weak price performance lately. However, the company's strong fundamentals, including its medical device technology and market position, suggest that it may be worth watching for the long-term.

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
- Opinions: 29
- Target Price (avg/high/low): 608.26 / 740.00 / 378.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-22 | 1.98 | 2.51B$ |
| 2025-07-23 | 1.84 | 2.44B$ |
| 2025-04-23 | 1.95 | 2.25B$ |
| 2024-10-18 | 1.59 | 2.04B$ |
| 2025-10-22 | 1.59 | 2.04B$ |

**Revenue and Profitability Analysis**

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $2.51B | 66.36% |
| 2025-06-30 | $2.44B | 66.31% |
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |

**Capital and Profitability Analysis**

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $16.93B | 4.16% |
| 2025-06-30 | $17.85B | 3.69% |
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |

**Comprehensive Analysis (Summary of previous items)**

Intuitive Surgical has experienced a weak price performance lately, but its strong fundamentals and medical device technology suggest that it may be worth watching for the long-term. The company's revenue and profitability have been improving, with a profit margin of 66.36% in the latest quarter. However, its equity has decreased, with a return on equity (ROE) of 4.16%. The analysts' consensus is a "Buy" rating with a target price of $608.26. Overall, the company's situation appears to be stable, and it may be worth considering for the long-term.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.